Related Experiment Video
Updated: Sep 8, 2025

The Influence of Liver Resection on Intrahepatic Tumor Growth
Published on: April 9, 2016
Investigating the influence of hepatic neoplasms on Bothrops venom biochemistry
Caroline Tie Vespasiano1, Caroline Serino-Silva2, Giovanni Perez Machado Silveira2
1Laboratory of Herpetology, Butantan Institute, São Paulo, SP, Brazil; Interinstitutional Graduate Program in Biotechnology (PPIB-IPT, IBU and USP), University of São Paulo (USP), São Paulo, SP, Brazil.
Abstract:
Snake envenoming is a relevant public health issue, especially in tropical regions worldwide. Bothrops venom is essential for antivenom production in Brazil; however, the impacts of hepatic neoplasms on venom composition remain unexplored. This study aimed to evaluate whether hepatic neoplasms and/or cysts influence the biochemical profile and enzymatic activity of venoms from five Bothrops species. Venoms from 17 snakes - 8 with hepatic alterations and 9 healthy - were analyzed using SDS-PAGE, Western blotting, ELISA, RP-HPLC, and enzymatic activity assays. The results revealed high intra- and interspecific variability, with no consistent pattern linking the presence of neoplasms to significant changes in venom protein composition or enzymatic activities. Occasional differences were observed in proteolytic, phospholipase A2, L-amino acid oxidase activities and Minimum Coagulant Dose in some individuals; however, these were not directly attributable to hepatic pathology. Immunoreactivity with the commercial antibothropic antivenom remained effective in all samples. The study concludes that hepatic neoplasms or cysts do not compromise venom biochemical integrity for antivenom production, reinforcing the viability of using these individuals for venom extraction in captivity for public health purposes.
More Related Videos
Related Concept Videos
Hepatic Drug Excretion: Influencing Factors
Hepatic Drug Clearance: Effect of Protein Binding
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...

